I saw an AP news article and then found a news release on what appears to be a potentially valuable screen for ovarian cancer, currently difficult to diagnose in early stages. If further studies pan out, I suspect screening for ovarian cancer in women will mirror current PSA screening in men for prostate cancer. It appears FDI (Fujirebio) is not a publicly traded company but is partnering with Becton Dickinson (BDX) which is. Here is a news release:
http://www.fdi.com/documents/news/050409.pdf
|
No Stocks are Harder to Find, or More Worth the Effort. They have the greatest potential for quick gains, but they're also the most difficult to find and time correctly. Now Zacks has perfected a system for identifying and profiting from turnaround stocks just as they begin a powerful rebound. Learn more here >>. |
| Take advantage of quick short-term moves, and profit from price moves in any direction. Trade options under the direction of an expert guide. Try it now and get a 90-day unconditional money-back guarantee. 50% OFF for a limited time! Zacks Options Trader >> |
| Make Big Bucks promoting Zacks products on your website! Click here to Learn about Zacks' Affiliate program. |
|
Ride Momentum Stocks to Quick Gains! The market is finally breaking out, creating the perfectd wave for investing in momentum stocks. Zacks is the king of fundamental analysis, but this service also uses technical indicators for the best possible timing. Click here to learn more >>. |

Read Neurodoc's blog in RSS


May 22, 2010
Share This